Aadi bioscience to participate in upcoming investor events

Los angeles, may 23, 2023 /prnewswire/ -- aadi bioscience, inc. (nasdaq: aadi), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mtor pathway genes, announced today participation at the following investor events: td cowen's 4th annual oncology innovation summit:  insights for asco & eha - the virtual event, taking place may 30 - 31, 2023, incorporates fireside chats hosted by members of td cowen research team that focus on various aspects of health care. scott giacobello, interim ceo and president and cfo of aadi, will participate in a fireside chat on tuesday, may 30, 2023, at 11:30 am et.
AADI Ratings Summary
AADI Quant Ranking